Understanding the Strengths and Limitations of Online Oocyte Cryopreservation Calculators.
Wolf AT, Minis E, Mahalingaiah S.
Semin Reprod Med. 2024 Jul 10. PMID: 38986483
Faculty Affiliate in the Department of Epidemiology
Epidemiology
Harvard T.H. Chan School of Public Health
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology, Part-time
Obstetrics Gynecology & Reproductive Bio. - MGH
Harvard Medical School
Shruthi Mahalingaiah is an assistant professor of environmental, reproductive, and women’s health in the Department of Environmental Health at the Harvard T.H. Chan School of Public health. She serves clinically as a physician specializing in ovulation disorders, reproductive endocrinology and infertility at the Massachusetts General Hospital in the Department of Obstetrics and Gynecology.
Research
Dr. Mahalingaiah’s research seeks to understand the association of environmental and modifiable risk factors on human reproduction as they pertain to the etiology and prevention of gynecological disease. Through physiology-informed research, she focuses on identifying environmental exposures associated with the development of polycystic ovary syndrome (PCOS) and metabolic sequelae. Her research encompasses three distinct areas: 1.) Air pollution and gynecologic disease incidence including cardiometabolic risk across the reproductive lifespan; 2.) Environmental toxicant exposures in the perinatal, perimenarchal, and adult time window with placental disease and ovulatory disorders; and 3.) Creation of diverse cohorts to study women’s health across the reproductive lifespan. She is currently funded by the March of Dimes, National Science Foundation, and is on the leadership team of the Apple Women’s Health study.
She was awarded the 2016 Endocrine Society Early Investigator award, an Ellison Family Foundation award, and an RSDP seed grant in 2017–2018 to create a pilot online study of ovulation and menstruation health. Supported by a Thomas J. Watson III Fellowship, she lived with indigenous shamans in the Ecuadorian Amazon Basin, Andes mountains, and Bali studying the role of ritual in the healing process. She was previously supported by K level funding from the Building Interdisciplinary Research Careers in Women’s’ Health (BIRCWH 2011–2014) and the Reproductive Scientist Development Program (RSDP 2104–2017) to study environmental exposures and incidence of benign gynecologic conditions.
Education
Dr. Mahalingaiah holds a BA from Middlebury College, an MD from Harvard Medical School, and an MS in epidemiology from Boston University’s School of Public Health. Prior to joining the Harvard Chan School, Dr. Mahalingaiah completed an OB/GYN residency at the Massachusetts General/Brigham and Women’s Hospital (MGH/BWH) combined program. She was a fellow in reproductive endocrinology and infertility at BWH which led to her appointment as an assistant professor of reproductive endocrinology and infertility in the Department of Obstetrics and Gynecology at Boston Medical Center and Boston University School of Medicine to serve the fertility aspirations of under-resourced populations. In 2016, she was appointed assistant professor in the department of epidemiology at Boston University School of Public Health and was appointed assistant professor in the department of physiology and biophysics at the Boston University School of Medicine the following year.
Wolf AT, Minis E, Mahalingaiah S.
Semin Reprod Med. 2024 Jul 10. PMID: 38986483
Mayette E, Scalise A, Li A, McGeorge N, James K, Mahalingaiah S.
BMC Womens Health. 2024 Jun 15. 24(1):346. PMID: 38877503
Babadi RS, Williams PL, Preston EV, Li Z, Smith RL, Strakovsky RS, Mahalingaiah S, Hauser R, Flaws JA, James-Todd T.
Environ Int. 2024 Jun. 188:108770. PMID: 38821016
Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A, Armour M, Rao V, Naidoo D, Maunder A, Yang G, Vaddiparthi V, Witchel SF, Pena A, Spritzer PM, Li R, Tay C, Mousa A, Teede H, Ee C.
J Clin Endocrinol Metab. 2024 May 17. 109(6):1630-1655. PMID: 38163998
Dresser C, Mahalingaiah S, Nadeau KC.
JAMA Netw Open. 2024 May 01. 7(5):e2412026. PMID: 38787564
Wang Z, Asokan G, Onnela JP, Baird DD, Jukic AMZ, Wilcox AJ, Curry CL, Fischer-Colbrie T, Williams MA, Hauser R, Coull BA, Mahalingaiah S.
JAMA Netw Open. 2024 May 01. 7(5):e2412854. PMID: 38809557
Wang Z, Jukic AMZ, Baird DD, Wilcox AJ, Li H, Curry CL, Fischer-Colbrie T, Onnela JP, Williams MA, Hauser R, Coull BA, Mahalingaiah S.
JAMA Netw Open. 2024 May 01. 7(5):e249657. PMID: 38700861
Silva EL, Mínguez-Alarcón L, Coull B, Hart JE, James-Todd T, Calafat AM, Ford JB, Hauser R, Mahalingaiah S.
Fertil Steril. 2024 May 01. PMID: 38697237
Burdeau JA, Stephenson BJK, Aris IM, Preston EV, Hivert MF, Oken E, Mahalingaiah S, Chavarro JE, Calafat AM, Rifas-Shiman SL, Zota AR, James-Todd T.
Environ Int. 2024 04. 186:108628. PMID: 38583297
Zad Z, Jiang VS, Wolf AT, Wang T, Cheng JJ, Paschalidis IC, Mahalingaiah S.
Front Endocrinol (Lausanne). 2024. 15:1298628. PMID: 38356959
In light of new findings that multiple tampon brands contain toxic metals, the FDA should consider stricter monitoring menstrual products, says Harvard Chan School's Shruthi Mahalingaiah.
As climate change continues to escalate, protecting maternal and infant health must be a priority, according to experts from Harvard Chan School.
The average age at menarche—the first menstrual period—has been decreasing among younger generations in the U.S., especially those belonging to racial minorities and lower socioeconomic statuses, according to a new study led by researchers at Harvard Chan School.
Having persistently irregular menstrual cycles appears to put women at heightened risk for cardiometabolic conditions, according to a large study from the Apple Women’s Health Study.
Menstrual cycle phases can influence individuals’ blood glucose levels—raising new possibilities for diabetes care, according to new research from Harvard Chan School.